BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11290607)

  • 1. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
    Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
    Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
    Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
    Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
    Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest.
    Ikezoe T; Chen SS; Heber D; Taguchi H; Koeffler HP
    Prostate; 2001 Dec; 49(4):285-92. PubMed ID: 11746275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.
    Campbell MJ; Elstner E; Holden S; Uskokovic M; Koeffler HP
    J Mol Endocrinol; 1997 Aug; 19(1):15-27. PubMed ID: 9278857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
    Steiner M; Priel I; Giat J; Levy J; Sharoni Y; Danilenko M
    Nutr Cancer; 2001; 41(1-2):135-44. PubMed ID: 12094616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ; Reddy GS; Koeffler HP
    J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Gemini vitamin D(3) analogs have potent antitumor activity.
    Saito T; Okamoto R; Haritunians T; O'Kelly J; Uskokovic M; Maehr H; Marczak S; Jankowski P; Badr R; Koeffler HP
    J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):151-6. PubMed ID: 18938245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
    Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
    Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells.
    James SY; Williams MA; Kelsey SM; Newland AC; Colston KW
    Biochem Pharmacol; 1997 Sep; 54(5):625-34. PubMed ID: 9337080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.
    Shen JC; Klein RD; Wei Q; Guan Y; Contois JH; Wang TT; Chang S; Hursting SD
    Mol Carcinog; 2000 Oct; 29(2):92-102. PubMed ID: 11074606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.
    O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells.
    Elstner E; Campbell MJ; Munker R; Shintaku P; Binderup L; Heber D; Said J; Koeffler HP
    Prostate; 1999 Aug; 40(3):141-9. PubMed ID: 10398275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.